NeuroSentry was featured in a BioBuzz interview highlighting our mission to transform how stroke is detected in patients who cannot undergo a conventional neurological examination.
The conversation explores the clinical challenge that inspired NeuroSentry and our work to develop an EEG-based platform capable of continuously analyzing brain activity for signs of cerebral ischemia and stroke.
By translating complex neurological signals into actionable information, NeuroSentry aims to help clinicians recognize neurological injury earlier, particularly in patients who are sedated, anesthetized, or otherwise unable to participate in a traditional neurological assessment.
Check out. the interview: https://www.youtube.com/shorts/XWx2Rp9W3Ig
